Hyloris Pharmaceuticals filing to FSMA for period ending 31 Dec 2023
Entity Hyloris Pharmaceuticals (6 filings)
LEI 875500LZIWS7QEQE0I73
Period end 2023-12-31
Language English
Validation 0 errors, 5 warnings, 0 inconsistencies
Downloaded from FSMA 2024-12-18 17:41:22
Added to filings.xbrl.org 2024-12-18 18:01:44
Source Financial Services and Markets Authority (FSMA)
Download from FSMA
Country Belgium (BE)
Hash e3267cfa